Trial Profile
Prospective study investigating the long-term tolerability of pralatrexate alone or in combination with oral bexarotene in relapsed or refractory mycosis fungoides
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 28 Nov 2015
Price :
$35
*
At a glance
- Drugs Bexarotene (Primary) ; Pralatrexate (Primary)
- Indications Mycosis fungoides
- Focus Adverse reactions; Therapeutic Use
- 28 Nov 2015 New trial record